{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-051593","form_type":"8-K","ticker":"ISPC","cik":"0001558569","company_name":"iSpecimen Inc.","filed_at":"2025-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.755341+00:00","generated_at":"2026-05-19T21:50:16.709278+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"iSpecimen receives Nasdaq delisting notice for failing to meet minimum stockholders' equity requirement","bullets":["Received Nasdaq letter on June 4, 2025 regarding non-compliance with Listing Rule 5550(b)(1) requiring minimum $2.5M stockholders' equity.","As of March 31, 2025, stockholders' equity was $1,668,513, below the $2.5M threshold; no alternative listing criteria met.","Company has 45 days to submit a compliance plan; if accepted by Nasdaq, may receive up to 180-day extension to regain compliance.","If plan not accepted or compliance not regained, Nasdaq may delist the common stock; Company can appeal to a Hearings Panel."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-051593","json":"https://secwatch.observer/filing/0001213900-25-051593.json","markdown":"https://secwatch.observer/filing/0001213900-25-051593.md","text":"https://secwatch.observer/filing/0001213900-25-051593.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000121390025051593/0001213900-25-051593-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000121390025051593/ea0244830-8k_ispecimen.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T21:50:16.709278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"42a05ee1d3d6ad73b4542a18ed776d3fc99599f0","claim":"iSpecimen Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"June 4, 2025, iSpecimen Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires a minimum of $2.5 million in stockholders’ equity for continued listing on the Nasdaq Capital Market. As reported in the Company’s Quarterly Report on Form 10-Q for the period ended March 31, 2025, the Company had stockholders’ equity of $1,668,513. Nasdaq further noted that the Company does not currently meet the alternative continued listing crite","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1558569/000121390025051593/0001213900-25-051593-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}